Biosimilars in rheumatology: understanding the rigor of their development.

Published

Journal Article (Review)

This article examines the current landscape of biosimilar development in rheumatology. As misperceptions about biosimilars exist regarding their comparability to the reference products for clinical use, we review the development paradigm with the goal of improving rheumatologists' understanding of the rigor with which biosimilars are developed. With an emphasis on European Union and US markets, it gives an overview of some of the challenges and issues related to biosimilar development that need to be considered by rheumatologists in this increasingly growing therapeutic space.

Full Text

Duke Authors

Cited Authors

  • Goel, N; Chance, K

Published Date

  • February 2017

Published In

Volume / Issue

  • 56 / 2

Start / End Page

  • 187 - 197

PubMed ID

  • 27241704

Pubmed Central ID

  • 27241704

Electronic International Standard Serial Number (EISSN)

  • 1462-0332

Digital Object Identifier (DOI)

  • 10.1093/rheumatology/kew206

Language

  • eng

Conference Location

  • England